FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2940963452> ?p ?o ?g. }

• W2940963452 endingPage "1208" @default.
• W2940963452 startingPage "1200" @default.
• W2940963452 abstract "Abstract Background The cystic fibrosis transmembrane conductance regulator (CFTR) modulators ivacaftor and lumacaftor/ivacaftor improve the status of existing infections in patients with cystic fibrosis (CF). It is unknown how well these drugs protect patients against incident infections. We hypothesized that CFTR modulator treatment would decrease new infections with Pseudomonas aeruginosa or Staphylococcus aureus. Methods We retrospectively studied a single‐center cohort of patients with CF during two time periods (2008‐2011, Era 1) and (2012‐2015, Era 2) based on the January 2012 approval of ivacaftor. Using Kaplan–Meier analysis, we compared the time to any new infection with P. aeruginosa , methicillin‐resistant S. aureus (MRSA), or methicillin‐sensitive S. aureus (MSSA) that was absent during a 2‐year baseline. We stratified the analysis based on whether patients received ivacaftor or lumacaftor/ivacaftor during Era 2. We used the log‐rank test and considered P < 0.05 statistically significant. Results For patients receiving ivacaftor or lumacaftor/ivacaftor in Era 2, there was a statistically significant delay in the time to new bacterial acquisition in Era 2 vs. Era 1 ( P = 0.008). For patients who did not receive CFTR modulators, there was a trend toward slower acquisition of new bacterial infections in Era 2 compared to Era 1, but this was not statistically significant ( P = 0.10). Conclusions Patients receiving ivacaftor or lumacaftor/ivacaftor for CF had significantly delayed acquisition of P. aeruginosa and S. aureus after these drugs were released. This method for analyzing incident infections may be useful for future studies of CFTR modulators and bacterial acquisition in CF registry cohorts." @default.
• W2940963452 created "2019-05-03" @default.
• W2940963452 creator A5000964652 @default.
• W2940963452 creator A5012680079 @default.
• W2940963452 creator A5020504141 @default.
• W2940963452 creator A5033337289 @default.
• W2940963452 creator A5073882804 @default.
• W2940963452 creator A5076937394 @default.
• W2940963452 creator A5080491822 @default.
• W2940963452 creator A5087265021 @default.
• W2940963452 creator A5089099197 @default.
• W2940963452 date "2019-04-22" @default.
• W2940963452 modified "2023-10-16" @default.
• W2940963452 title "Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor" @default.
• W2940963452 cites W1555657499 @default.
• W2940963452 cites W1589654967 @default.
• W2940963452 cites W1602614918 @default.
• W2940963452 cites W1810815273 @default.
• W2940963452 cites W1951470933 @default.
• W2940963452 cites W1954257474 @default.
• W2940963452 cites W1986683703 @default.
• W2940963452 cites W2027464873 @default.
• W2940963452 cites W2039462910 @default.
• W2940963452 cites W2044380511 @default.
• W2940963452 cites W2051836609 @default.
• W2940963452 cites W2054716883 @default.
• W2940963452 cites W2059161264 @default.
• W2940963452 cites W2062137132 @default.
• W2940963452 cites W2066510676 @default.
• W2940963452 cites W2068148539 @default.
• W2940963452 cites W2077003946 @default.
• W2940963452 cites W2101012696 @default.
• W2940963452 cites W2113606945 @default.
• W2940963452 cites W2128547781 @default.
• W2940963452 cites W2135668587 @default.
• W2940963452 cites W2140868856 @default.
• W2940963452 cites W2142593859 @default.
• W2940963452 cites W2144292013 @default.
• W2940963452 cites W2149520619 @default.
• W2940963452 cites W2149905331 @default.
• W2940963452 cites W2168894283 @default.
• W2940963452 cites W2169172209 @default.
• W2940963452 cites W2172683933 @default.
• W2940963452 cites W2236839872 @default.
• W2940963452 cites W2317332612 @default.
• W2940963452 cites W2556885577 @default.
• W2940963452 cites W2589766919 @default.
• W2940963452 cites W2609197436 @default.
• W2940963452 cites W2623866723 @default.
• W2940963452 cites W2735213226 @default.
• W2940963452 cites W2765825922 @default.
• W2940963452 cites W4206217612 @default.
• W2940963452 cites W4234589892 @default.
• W2940963452 doi "https://doi.org/10.1002/ppul.24341" @default.
• W2940963452 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6641998" @default.
• W2940963452 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31012285" @default.
• W2940963452 hasPublicationYear "2019" @default.
• W2940963452 type Work @default.
• W2940963452 sameAs 2940963452 @default.
• W2940963452 citedByCount "16" @default.
• W2940963452 countsByYear W29409634522019 @default.
• W2940963452 countsByYear W29409634522020 @default.
• W2940963452 countsByYear W29409634522021 @default.
• W2940963452 countsByYear W29409634522022 @default.
• W2940963452 crossrefType "journal-article" @default.
• W2940963452 hasAuthorship W2940963452A5000964652 @default.
• W2940963452 hasAuthorship W2940963452A5012680079 @default.
• W2940963452 hasAuthorship W2940963452A5020504141 @default.
• W2940963452 hasAuthorship W2940963452A5033337289 @default.
• W2940963452 hasAuthorship W2940963452A5073882804 @default.
• W2940963452 hasAuthorship W2940963452A5076937394 @default.
• W2940963452 hasAuthorship W2940963452A5080491822 @default.
• W2940963452 hasAuthorship W2940963452A5087265021 @default.
• W2940963452 hasAuthorship W2940963452A5089099197 @default.
• W2940963452 hasBestOaLocation W29409634522 @default.
• W2940963452 hasConcept C126322002 @default.
• W2940963452 hasConcept C2776502428 @default.
• W2940963452 hasConcept C2776938444 @default.
• W2940963452 hasConcept C2777637488 @default.
• W2940963452 hasConcept C2778428886 @default.
• W2940963452 hasConcept C2779489039 @default.
• W2940963452 hasConcept C523546767 @default.
• W2940963452 hasConcept C54355233 @default.
• W2940963452 hasConcept C71924100 @default.
• W2940963452 hasConcept C86803240 @default.
• W2940963452 hasConceptScore W2940963452C126322002 @default.
• W2940963452 hasConceptScore W2940963452C2776502428 @default.
• W2940963452 hasConceptScore W2940963452C2776938444 @default.
• W2940963452 hasConceptScore W2940963452C2777637488 @default.
• W2940963452 hasConceptScore W2940963452C2778428886 @default.
• W2940963452 hasConceptScore W2940963452C2779489039 @default.
• W2940963452 hasConceptScore W2940963452C523546767 @default.
• W2940963452 hasConceptScore W2940963452C54355233 @default.
• W2940963452 hasConceptScore W2940963452C71924100 @default.
• W2940963452 hasConceptScore W2940963452C86803240 @default.
• W2940963452 hasFunder F4320309129 @default.
• W2940963452 hasFunder F4320337338 @default.
• W2940963452 hasFunder F4320337611 @default.

• next